Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Drug and Alcohol Dependence|October 7, 2023
Racial and ethnic disparities in biomarkers of exposure and potential harm among U.S. adult exclusive e-cigarette users: 2013-2019Hongying Daisy Dai, Nikki Nollen, Stephen Rennard, et al.
Respiratory Medicine|March 26, 2017
A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary diseaseAnthony D'Urzo, Stephen Rennard, Edward Kerwin, et al.
Chest|September 25, 2010
Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trialDonald P Tashkin, Stephen Rennard, J Taylor Hays, et al.
COPD|May 30, 2013
Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, recommendations of the COPD FoundationStephen Rennard, Byron Thomashow, James Crapo, et al.
Heliyon|November 6, 2019
TGF-β induces a heart failure phenotype via fibroblasts exosome signalingHesham Basma, Adelaide N Johanson, Kajari Dhar, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|April 29, 2021
The effect of long-acting dual bronchodilator therapy on exercise tolerance, dynamic hyperinflation, and dead space during constant work rate exercise in COPDWilliam W Stringer, Janos Porszasz, Min Cao, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 21, 2016
Interpreting patient-reported outcomes from clinical trials in COPD: a discussionPaul W Jones, Stephen Rennard, Maggie Tabberer, et al.
Archives of Internal Medicine|August 16, 2006
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-upMitchell Nides, Cheryl Oncken, David Gonzales, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
The COPD Foundation Pocket Consultant GuideByron Thomashow, James Crapo, Barbara Yawn, et al.
Respiratory Medicine|January 29, 2013
A randomised trial of fluticasone furoate/vilanterol (50/25 μg; 100/25 μg) on lung function in COPDEdward M Kerwin, Catherine Scott-Wilson, Lisa Sanford, et al.
Pageof 10